Larvol Delta - Combination-therapeutics-for-hepatitis-delta-virus-infection-implications-of-the-tobevibartelebsiran-SOLSTICE-phase-2-trial

tobevibart (VIR-3434) - Vir Biotech

elebsiran (VIR-2218) - Alnylam, Vir Biotech

http://www.ncbi.nlm.nih.gov/pubmed/42592408

Joseph K Lim; Peter D Block

Aug 14, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next